Concord Wealth Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52K Buy
+82
New +$5.46K ﹤0.01% 646
2026
Q1
Sell
-81
Closed -$5.38K 348
2025
Q4
$5.38K Buy
+81
New +$5.24K ﹤0.01% 614
2022
Q3
Sell
-32
Closed -$2K 410
2022
Q2
$2K Sell
32
-396
-93% -$36.1K ﹤0.01% 1008
2022
Q1
$55K Buy
428
+16
+4% +$1.75K 0.01% 411
2021
Q4
$55K Buy
412
+352
+587% +$50.6K 0.01% 438
2021
Q3
$8K Sell
60
-12
-17% -$1.51K ﹤0.01% 496
2021
Q2
$8K Buy
+72
New +$6.91K ﹤0.01% 654

Other funds holding DXCM

Concord Wealth Partners's DXCM Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in DexCom (DXCM) in Q2 2026: 82 shares worth $5.52K. The stake represents ﹤0.01% of the portfolio and ranks #646 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in DXCM as recently as Q4 2025.

Concord Wealth Partners first reported a position in DXCM in Q2 2021 and has held it in 7 quarters since. The position peaked at $55K in Q1 2022. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Concord Wealth Partners held 82 shares of DexCom worth $5.52K as of Q2 2026.
  • DexCom was a new Concord Wealth Partners position in Q2 2026.
  • DexCom made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #646 holding.
  • Concord Wealth Partners first reported a position in DexCom in Q2 2021 and has held it in 7 quarters since.
  • Concord Wealth Partners's DexCom position peaked at $55K in Q1 2022.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.